We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

EVOTEC Announces RESEARCH Agreement on Fragment-Based Drug Discovery with Cubist

News   Jul 15, 2009

 
EVOTEC Announces RESEARCH Agreement on Fragment-Based Drug Discovery with Cubist
 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

From Mirror-image Biology to Enhanced Therapeutic Proteins

News

Biomolecules are being synthesized in their mirror-image form, as part of a bigger long-term goal: to create simple, artificial biological systems in mirror-image form that correspond to those in nature but do not interact with the environment.

READ MORE

It’s Not Easy Being Green

News

A team of researchers have gained insight into the genes behind the photosynthetic machinery plants require to harness sunlight for growth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE